Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for January 6th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 6th:

Realogy Holdings Corp. (RLGY - Free Report) : This provider of residential real estate services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 46.9% over the last 60 days.

 

Realogy has a price-to-earnings ratio (P/E) of 5.99, compared with 39.20 for the industry. The company possesses a Value Score of A.

 

Shinhan Financial Group Co., Ltd. (SHG - Free Report) : This provider of financial products and services has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 40.5% over the last 60 days.

 

Shinhan Financial has a price-to-earnings ratio (P/E) of 4.90, compared with 9.60 for the industry. The company possesses a Value Score of B.

 

Tsakos Energy Navigation Limited (TNP - Free Report) : This provider of seaborne crude oil and petroleum product transportation services has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 33.3% over the last 60 days.

 

Tsakos Energy Navigation has a price-to-earnings ratio (P/E) of 3.91, compared with 10.00 for the industry. The company possesses a Value Score of A.

 

Western Midstream Partners, LP (WES - Free Report) : This natural gas, condensate, natural gas liquids, and crude oil provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 20.3% over the last 60 days.

 

Western Midstream has a price-to-earnings ratio (P/E) of 6.41, compared with 8.00 for the industry. The company possesses a Value Score of A.

 

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>